Literature DB >> 30292575

The consequences of overcoming the human skin barrier by siloxanes (silicones) Part 1. Penetration and permeation depth study of cyclic methyl siloxanes.

Dominika Krenczkowska1, Krystyna Mojsiewicz-Pieńkowska2, Bartosz Wielgomas3, Krzysztof Cal4, Rafał Bartoszewski5, Sylwia Bartoszewska6, Zbigniew Jankowski7.   

Abstract

Dynamic production of cyclic siloxanes: octamethylcyclotetrasiloxane D4, decamethylcyclopentasiloxane D5 and dodecamethylcyclohexasiloxane D6 increases their concentrations in environment. It is considered that both environmental pollution and the usage of personal care products and cosmetics containing cyclic siloxanes can be the main source of the human exposure by transdermal route. The aim of the study was to verify the possibility to overcome the skin barrier by cyclic siloxanes (ATR-FTIR and GC-FID), evaluation of diffusion pathway to stratum corneum SC (Fluorescence microscopy), and determination of depth of permeation to deeper skin layers: epidermis and dermis (ATR-FTIR) and also of potential interaction with SC lipids and proteins (Fluorescence microscopy, ATR-FTIR) and the cytotoxicity studies against HaCaT cells (MTT test). The results show that D4, D5 and D5 can penetrate to SC and permeate into the deeper layers of the skin: epidermis and dermis. The quantitative analysis (GC-FID) showed that total cumulative doses for D4, D5 and D6 were: 42.50; 95.37 and 77.19 μg/cm2/24 h, respectively. The microscopic analysis proved, transepidermal route through the lipid matrix as well as through the canyons (intercluster spaces) were a diffusion pathway to the SC as well as disruption of human SC lipid structure by: D4 (the most), D5 and D6 (the least). The cytotoxicity studies demonstrated that the tested range of concentrations of D5 and D6 (up to 300 mM, 111 300 mg and 133 500 mg respectively) did not impaired the HaCaT growth, while D4 had IC50 value of 40 098 mM ± 7.94 (10 906 ± 872,5 mg).
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diffusion to human skin; Interactions with lipid and protein; Percutaneous absorption; Siloxanes; Skin penetration; Skin permeation

Mesh:

Substances:

Year:  2018        PMID: 30292575     DOI: 10.1016/j.chemosphere.2018.09.154

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  2 in total

1.  Ex Vivo Human Skin is not a Barrier for Cyclic Siloxanes (Cyclic Silicones): Evidence of Diffusion, Bioaccumulation, and Risk of Dermal Absorption Using a New Validated GC-FID Procedure.

Authors:  Dominika Krenczkowska; Krystyna Mojsiewicz-Pieńkowska; Bartosz Wielgomas; Dagmara Bazar; Zbigniew Jankowski
Journal:  Pharmaceutics       Date:  2020-06-24       Impact factor: 6.321

2.  Evidence of Skin Barrier Damage by Cyclic Siloxanes (Silicones)-Using Digital Holographic Microscopy.

Authors:  Krystyna Mojsiewicz-Pieńkowska; Ewa Stachowska; Dominika Krenczkowska; Dagmara Bazar; Frans Meijer
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.